IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.
about
Evidence for OTUD-6B participation in B lymphocytes cell cycle after cytokine stimulationIdentification of human CCR8 as a CCL18 receptorWheat allergy: diagnosis and managementRecent discoveries and emerging therapeutics in eosinophilic esophagitisRole of Endoscopy in Diagnosis and Management of Pediatric Eosinophilic EsophagitisAllergic mechanisms of Eosinophilic oesophagitisEosinophilic EsophagitisDo We Know What Causes Eosinophilic Esophagitis? A Mechanistic UpdateEosinophilic esophagitisThe pathophysiology of eosinophilic esophagitisEosinophilic disorders of the gastro-intestinal tract: an updateProton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differencesCommon variants at 5q22 associate with pediatric eosinophilic esophagitisSerum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis.High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.Genetic and epigenetic underpinnings of eosinophilic esophagitisThe link between allergies and eosinophilic esophagitis: implications for management strategiesInterleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils.Effect of topical beclomethasone on inflammatory markers in adults with eosinophilic esophagitis: A pilot study.Toward uniformity in the diagnosis of eosinophilic esophagitis (EoE): the effect of guidelines on variability of diagnostic criteria for EoE.Diagnosis of eosinophilic esophagitis: current approach and future directions.Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51.Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophiliaRPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human StudyEfficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis.Involvement of mast cells in eosinophilic esophagitis.Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis.Non- and semi-invasive methods of monitoring eosinophilic esophagitis.Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy.MiR-375 is downregulated in epithelial cells after IL-13 stimulation and regulates an IL-13-induced epithelial transcriptome.Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencingMarkers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitisComparative analysis of FcεRI expression patterns in patients with eosinophilic and reflux esophagitis.MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targetsDendritic cell and T cell responses in children with food allergy.Roles and regulation of gastrointestinal eosinophils in immunity and disease.Mechanical properties of the esophagus in eosinophilic esophagitis.GWAS identifies four novel eosinophilic esophagitis lociHistologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.
P2860
Q21136036-86B1328C-248E-4876-9407-B280F5DA95E3Q24618546-DFDD1715-CE83-4515-BB84-B36D71D259CBQ26765021-3E6F1A18-3030-49A6-9DD9-0844DC35EF85Q26768277-B34D1DF1-9484-4F7B-8F34-25E2C430EF77Q26776253-661AB57F-1B33-4348-8C12-D2E580A73529Q26778315-C73CCD82-2860-4515-8465-4F792168252EQ26778699-00B35BD1-0909-4182-94A7-3698645A82BCQ26865894-4AA88DDE-1A5A-434D-877F-D352145CC594Q27004593-2C2293CA-1370-417D-A6AC-19749961A821Q27011378-EE908F9C-2F6C-48F8-A5E0-698E1C944514Q28066026-32C141D0-A1F4-45C0-BF47-6F03AEDDC588Q28082447-C4735490-A4E3-4052-8488-7FB46F4E28A4Q28943383-AFABFB0F-92E8-439E-AEB2-3E2769FF0D78Q30432047-13A49700-9D52-4A82-8759-8EC100306726Q30554334-206F153D-963A-4DF3-B1A8-BBE35BAFFB68Q33606257-0C43872E-0B18-4FAD-9000-378F98F90EB4Q33649482-E8367434-12A6-40D5-8674-BD4E64937040Q33716561-2107817E-FFEB-4C31-B8E2-CAAEE2073A99Q33791211-F735FF60-285D-4060-93B5-776BB61ABA34Q33815129-65F7CC88-2065-4561-9668-485CCBE7C2A3Q33832425-9364A1D4-7256-43E9-833B-6291E2B269FAQ33834088-C75ECA16-F13B-48C1-9FF0-D4B431A77611Q33838272-8D5125DE-49DB-44B4-8B4B-E1627EA31962Q33844398-5EBAFCD5-86D2-414A-85CB-B0428724D24FQ33934643-FE00A012-3952-4FAC-B0BD-F8DBCA997202Q33987527-0CE519F7-B115-467A-8D18-F53E9B41BA3FQ33996008-81451E9A-FF19-42BB-90BC-DF1C7689CEE1Q34026678-51B04E62-659E-40A8-BC2C-574C3C1E287CQ34045448-B5F54B0C-A93C-45CB-9032-3947E7BC6927Q34131643-548734E3-BD0F-471C-B84B-D365A72C86BBQ34143183-E336A04D-9380-4694-A64E-430F0F9CF8D8Q34166618-42835F39-4D0C-4F13-A16C-512C3BF18EAEQ34247074-32119F24-A9E3-4FA6-8AD5-146C302E40DEQ34258717-AC085F9D-6AE8-4A2F-BA28-E18890F3468AQ34345019-4EF6B70A-5FBE-4362-BC3F-BAC0120C8C67Q34424827-AC16801E-B768-4962-A1AA-246EFCB78925Q34430214-18D56B2D-883A-4EE6-AB3A-93F2A6F47134Q34432477-C70A77B9-78BC-4D26-A08D-2EC74944DE2AQ34545768-A2C6F687-E51C-41FE-884F-B7FD91A682EAQ34624093-A8818940-268A-4072-BF16-DF7E92A6650E
P2860
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
IL-13 involvement in eosinophi ...... sibility with glucocorticoids.
@en
type
label
IL-13 involvement in eosinophi ...... sibility with glucocorticoids.
@en
prefLabel
IL-13 involvement in eosinophi ...... sibility with glucocorticoids.
@en
P2093
P50
P1476
IL-13 involvement in eosinophi ...... rsibility with glucocorticoids
@en
P2093
Carine Blanchard
Marc E Rothenberg
Margaret H Collins
Melissa K Mingler
Philip E Putnam
Susanne I Wells
Yi Ying Wu
P304
P356
10.1016/J.JACI.2007.10.024
P407
P577
2007-12-01T00:00:00Z